[email protected]+1 737 734 2707
Global Hyaluronic Acid Market
Request CustomizationSchedule a Call
  1. Home
  2. Chemicals And Materials
  3. Global Hyaluronic Acid Market

Global Hyaluronic Acid Market 2024–2033

Market size, share and growth analysis by grade, application and end-users, across all major regions and key countries, with forecasts for 2022–2030. The competitive landscape profiles 17+ companies, including Allergan, Genzyme Corporation and Sanofi.

  • Updated:
  • Report ID:22249
  • Author:Ayush Kadam
  • 220+ Pages
  • 17+ Companies
  • Base year 2021
  • Forecast 2022-2030
  • Global coverage
USD 1.26 Bn
Market size, 2022
USD 2.6 Bn
Forecast, 2030
8%
CAGR, 2022-2030
Asia Pacific
Largest region
North America
Fastest-growing region
OverviewTable of ContentsSegmentsCompany Listing

The global hyaluronic acid market was valued at USD 1.26 Bn in 2022 and is projected to reach USD 2.6 Bn by 2030, growing at a CAGR of 8%. Asia Pacific is the largest regional market and North America is growing fastest.

Reports Description

According to Custom Market Insights (CMI), The Global Hyaluronic Acid Market was estimated at USD 1.1 billion in 2021 and is expected to reach USD 1.26 billion in 2022 and is anticipated to reach around USD 2.60 billion by 2030, growing at a CAGR of roughly 8% between 2022 and 2030. Our research report offers a 360-degree view of the Hyaluronic Acid market’s drivers and restraints, coupled with their impact on demand during the projection period. Also, the report examines global opportunities and competitive analysis for the Hyaluronic Acid market.

Hyaluronic Acid Market Size 2022 to 2030

To learn more about this report - request a sample report PDF

  • The fluids surrounding our eyes and joints, which serve as a lubricant and cushion for the tissues, have the highest quantities of hyaluronic acid. This glycosaminoglycan is naturally present in our bodies. It aids in keeping the skin's moisture levels stable. Due to its ability to hold moisture, hyaluronic acid is frequently utilized in skincare products to promote softer, smoother, and more moisturized skin. For those with low quantities of hyaluronic acid, nutritional supplements containing hyaluronic acid are also sold on the market. Such glycosaminoglycan is a crucial lubricant in body joints and is also sought after in the medical sector to treat osteoarthritic joints' inflammatory problems.
  • Hyaluronic acid is obtained from rooster combs or produced in a laboratory by bacteria. Hyaluronic acid injections into the knee have been approved by the FDA for individuals with osteoarthritis of the knee. Patients with cataracts might also receive it as an injection into the eye. In 2021, the cosmetics application market had the largest market share. Dermal fillers are becoming popular, which is the key factor driving demand.
  • According to L'Oréal's Cosmetics Market Report 2020, COVID-19 had a substantial impact on the cosmetics market, causing a fall of about 8% in the first two quarters. However, the same survey claims that the existence of e-commerce platforms helped mitigate the effect to some extent, with online cosmetic sales expected to increase by 40% globally by the year 2020.
  • However, a study of 1000 US women conducted by the American Society of Plastic Surgeons in April 2021 found that 70% of them planned to get a cosmetic surgery operation or a minimally invasive procedure after COVID-19. This demand will aid in the market's recovery when COVID-19's impacts start to fade.

Report Scope

The study's focus is on Hyaluronic Acid market analysis on a global scale, and market sizing includes the income generated by these solutions provided by different market players. In order to support the market projections and growth rates over the anticipated period of 2022-2030, the study additionally monitors important market factors, underlying growth influencers, and significant vendors active in the sector. The study also examines how COVID-19 has affected the ecology generally. The scope of the study includes market sizing and forecast for segmentation by grade, application, end-user, and geography.

Feature of the Report Details
Market Size in 2021 USD 1.1 Billion
Projected Market Size in 2030 USD 2.60 Billion
Market Size in 2022 USD 1.26 Billion
CAGR Growth Rate 8% CAGR
Base Year 2023
Forecast Period 2024-2033
Prominent Players Allergan, Genzyme Corporation, Sanofi, Anika Therapeutics Inc., Salix Pharmaceuticals, F. Hoffmann-La Roche Ag, Seikagaku Corporation, Galderma Laboratories L.P., Smith & Nephew Plc, Zimmer Biomet, Ferring B.V., HTL Biotechnology, Lifecore Biomedical Llc, Shiseido Company Limited, LG Life Sciences Ltd (LG Chem.), Bloomage Biotechnology Corporation Limited, Maruha Nichiro Inc., and Others
Key Segment By Grade, Application, End-users, and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors, and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfill your requirements for research.

Key Market Dynamics

  • The aging population and the development of technologically sophisticated products are expected to drive market growth. In the upcoming years, the industry's growth is anticipated to be driven by the growing preference for minimally invasive procedures and the need for quicker outcomes. The advent of cost-effective treatments and products, the aging population, growing aesthetic consciousness, and technology advancements are a few of the causes propelling the industry's expansion.
  • The number of aesthetic operations being performed is rising as a result of an increase in plastic surgeons and cosmetic surgery offices. The industry is being driven by the increasing use of nonsurgical cosmetic procedures like Botox and injectable hyaluronic acid. During the projection period, new product developments and an increase in the use of business strategies by important market participants, such as mergers and acquisitions, are expected to fuel growth. Hyaluronic acid has a number of health advantages that will increase demand, including moisture retention, quicker wound healing, relief from joint pain, prevention of dry eyes and discomfort, and preservation of bone strength.
  • Two significant aspects that are projected to contribute to the expansion of the global hyaluronic acid market during 2022-2030 are the rise in chronic diseases and the rising cost of healthcare services. Additionally, the market for hyaluronic acid is growing as a result of minimally invasive procedures and rising awareness of beauty and wellness.

Osteoarthritis Application Led the Hyaluronic Acid Market

  • In 2021, the OA led the sector globally and generated more than 40% of total sales. Due to a growth in the number of elderly people and a growing preference for minimally invasive procedures, the business is predicted to expand. Nearly 90% of viscosupplement prescriptions are meant to treat knee osteoarthritis. Both corticosteroids and hyaluronic acid injections can be used to treat osteoarthritis. According to the Osteoarthritis Research Society International (OARSI), the U.S., however, viscosupplementation is marginally more successful than corticosteroids.
  • Viscosupplements are becoming more well-liked as a treatment, notwithstanding the large percentage of painkillers in pain management. The U.S. FDA approved the use of hyaluronan as a therapy for osteoarthritis in 1997, and it has since garnered a significant market share. The osteoarthritis market is further divided into three categories: single injections, three injections, and five injections. Despite having greater treatment costs than its competitors, the market has generally accepted the single hyaluronic acid injection. Single injections are more convenient and require fewer trips to the hospital while also causing less discomfort and negative side effects.
  • Over the forecast period, the market growth is also anticipated to be aided by the rising occurrences of obesity and the growing senior population. Dermal fillers are the most popular and nonsurgical injectable therapy, specifically used to address soft tissue abnormalities on the face, according to the American Society of Plastic Surgeons (ASAPS). Dermal fillers made of hyaluronic acid are frequently used for aesthetic procedures such as reducing nasolabial folds, dark circles, eye wrinkles, and scarring. Hyaluronic acid injections are simple to administer, efficient, and substantially less expensive; these benefits are anticipated to fuel growth throughout the course of the forecast period.

Competitive Landscape

Tier-1 and tier-2 firms are prevalent in the global hyaluronic acid market. All of the companies in the industry are vying for the largest possible portion of the market, which is very competitive. Limited government approval and licenses and high investment in hyaluronic acid research and development boost rivalry among the competitors.

Our market analysis includes a section specifically devoted to key players operating in the Hyaluronic Acid Market. Our analysts give an overview of each player's financial statements, along with product benchmarking and SWOT analysis. The competitive landscape section includes key development strategies, market share analysis, and market positioning analysis of the mentioned competitors globally.

  • 2021: Three different types of hyaluronic acid have been introduced by Royal DSM, a multinational scientific corporation involved in nutrition, health, and sustainable living. These are HYA-ACTTM M Medium Molecular Weight products, which improve skin moisture and fortify the barrier of defense. While HYA-ACTTM XS Very Small Molecular Weight (MW 37-56 kDa) delivers a continual burst of strong hydration and smoothens out fine lines, HYA-ACTTM S Small Molecular Weight (MW 200-400 kDa) locks in moisture for an even greater hydration boost.
  • 2020: Juvederm Voluma XC, a new hyaluronic acid product approved by AbbVie, is intended to improve the chin profile in adults.

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Market share analysis

Global Hyaluronic Acid Market 2022–2030 (By Application)
Global Hyaluronic Acid Market 2022–2030 (By End-Users)

To learn more about this report - request a sample report PDF

Global Hyaluronic Acid Market 2024–2033

Updated: August 2026 · Formats: PDF, Excel, PPT

Buy NowDownload SampleSchedule a CallRequest Customization

Frequently asked questions

Which region will dominate the global Hyaluronic Acid market?

"North America" region will lead the global Hyaluronic Acid market during the forecast period 2022 to 2030.

Which are the driving factors of the Hyaluronic Acid market?

The key factors driving the market are the hyaluronic acid market growth include increasing aesthetic consciousness, the aging population, the introduction of cost-effective treatments and products, and technological advancements.

Who are the top players operating in the Hyaluronic Acid market?
The key players operating in the Hyaluronic Acid market are Allergan, Genzyme Corporation, Sanofi, Anika Therapeutics Inc., Salix Pharmaceuticals, F. Hoffmann-La Roche Ag, Seikagaku Corporation, Galderma Laboratories L.P., Smith & Nephew Plc, Zimmer Biomet, Ferring B.V., HTL Biotechnology, Lifecore Biomedical Llc, Shiseido Company Limited, LG Life Sciences Ltd (LG Chem.), Bloomage Biotechnology Corporation Limited, Maruha Nichiro Inc.
What will be the CAGR of global Hyaluronic Acid market?

The global Hyaluronic Acid market is expanding growth with a CAGR of approximately 8% during the forecast period (2022 to 2030).

What is the existing size of Hyaluronic Acid market?

The global Hyaluronic Acid market size was valued at USD (1.1 billion) in 2021 and it is projected to reach around USD (2.6 billion) by 2030.

Meet the team

Ayush Kadam

Ayush Kadam

Author · Sr. Research Analyst

Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.

Read more about Ayush Kadam

More Chemicals And Materials reports

Free sampleBuy report

Free sample

Get the sample report

Global Hyaluronic Acid Market: sample pages and table of contents by email.

Security codeCode didn’t load.

We use these details only to answer this request. Privacy policy